Idx20 Inc
IDX20 Inc, located in Brookline, MA, specializes in rapid and highly accurate diagnostic assays that enhance healthcare outcomes through real-time data monitoring and sharing. Their innovative technology combines affordability and ease of use, enabling patients to self-quarantine and healthcare decision-makers to take timely action during potential epidemics.
Founded by MIT Professor Lee Gehrke, IDX20 focuses on developing proprietary screening methods for antibodies and point-of-care technologies, with a strong emphasis on rapid response during outbreaks. The company's leadership team, including CEO Irene Bosch and Research and Development Leader Helena de Puig, brings extensive experience from both academia and industry to drive advancements in diagnostic solutions.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.